Themis2 is not required for B cell development, activation, and antibody responses by Hartweger, H et al.
The Journal of Immunology
Themis2 Is Not Required for B Cell Development, Activation,
and Antibody Responses
Harald Hartweger,* Edina Schweighoffer,* Sophia Davidson,* Matthew J. Peirce,†,1
Andreas Wack,* and Victor L. J. Tybulewicz*
Themis1 is a protein implicated in transducing signals from the TCR. Mice deficient in Themis1 show a strong impairment in T cell
selection in the thymus and defective T cell activation. The related Themis2 protein is expressed in B cells where it associates with
signaling proteins Grb2 and Vav1, and is tyrosine phosphorylated after BCR stimulation. Thus, it has been proposed that Themis2may
transduce BCR signals, and hence play important roles in B cell development and activation. In this article, we show that Themis2 is
expressed in all developing subsets of B cells, inmature follicular andmarginal zone B cells, and in activated B cells, including germinal
center B cells and plasma cells. In contrast, B lineage cells express no other Themis-family genes. Activation of B cells leads to reduced
Themis2 expression, although it remains the only Themis-family protein expressed. To analyze the physiological function of Themis2,
we generated a Themis2-deficient mouse strain. Surprisingly, we found that Themis2 is not required for B cell development, for ac-
tivation, or for Ab responses either to model Ags or to influenza viral infection. The Journal of Immunology, 2014, 193: 700–707.
T
hemis-family proteins are defined by the presence of a
cysteine-containing, all-b in Themis (CABIT) domain
(1). The family can be traced down to cnidarians, but in
mammals it is composed of five members: Themis1 (originally
Themis, but in this article termed Themis1 for clarity), Themis2,
Themis3, Garem, and Gareml. The three Themis proteins share
a similar structure including two consecutive CABIT domains and
a proline-rich region (PRR), whereas Garem and Gareml contain
one CABIT domain, a PRR, and a SAM domain (1–3). Themis1
and Themis2 show high conservation between each other, and
both have a putative nuclear localization signal (NLS) and con-
served C-terminal tyrosine residues, which serve as SH2-binding
sites upon phosphorylation (4–7).
Signals from the BCR and TCR play critical roles in the de-
velopment, survival, and activation of B and T lymphocytes. Several
studies showed that Themis1 is essential for normal T cell devel-
opment (1, 4, 5, 8, 9). In the absence of Themis1, positive selection
of CD4+CD8+ double-positive thymocytes is impaired. Themis1 is
phosphorylated after TCR stimulation, suggesting that Themis1
participates in signaling from the TCR (4, 7, 10–12). A recent study
showed that Themis1 dampens signaling in thymocytes after low-
affinity TCR stimulation, which normally results in positive selec-
tion, but when Themis1 is absent, such low-affinity stimulation
results in increased TCR signaling and hence negative selection (13).
In comparison, little is known about Themis2. Studies in cancer
cell lines suggested a role for Themis2 in differentiation and
proliferation (14). Subsequently, Themis2 was shown to be in-
volved in LPS-induced TNF-a production in RAW cells and pri-
mary human macrophages where it interacts with Lyn, Grb2, and
Vav1 (6). Themis2 also associates with Grb2 and Vav1 in B cells
and is phosphorylated after BCR stimulation (7). Furthermore,
expression of Themis2 in the T cell lineage rescues thymocyte
development in Themis1-deficient mice, suggesting that Themis1
and Themis2 carry out similar functions (7).
Strikingly, Themis1 and Themis2 show mutually exclusive
expression: Themis1 is expressed in T cells, whereas Themis2 is
expressed in B cells, macrophages, and dendritic cells (http://www.
immgen.org). It has been noted for a long time that there are
strong similarities between BCR and TCR signaling pathways
(15); often one protein will exert a certain function in T cells,
whereas its paralogue performs a similar function in B cells.
Given the important role for Themis1 in T cell development and
the high degree of similarity between Themis1 and Themis2, we
hypothesized that Themis2 may have a critical function in B cell
development or activation.
In this article, we show that Themis2 is expressed in all subsets of
developing and mature B cells, and that no other Themis-family
member is expressed in the B cell lineage. Furthermore, we show
that Themis2 expression is downregulated after B cell activation.
However, despite this nonredundant expression pattern, we find that,
surprisingly, in the absence of Themis2, B cell development, acti-
vation, and Ab responses are unaffected.
Materials and Methods
Mice
The embryonic stem cell line JM8.F6 with the Themis2tm1a(KOMP)Wtsi
targeted allele (http://www.komp.org) was used to generate C57BL/6J-
Themis2tm1a(KOMP)Wtsi/Nimr mice. These were crossed to C57BL/6J-Tg
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(ACTFLPe)9205Dym mice (16) and to C57BL/6J-Tg(Prm-cre)70Og mice
(17) to delete the frt-flanked lacZ reporter and the loxP-flanked exon4 of
Themis2 respectively, generating C57BL/6J-Themis2tm1d(KOMP)Wtsi/Nimr
mice (Themis2KO). All experiments used age- and sex-matched littermate
control animals. Other strains used: B6.SJL-Ptprca/Nimr (CD45.1+),
C57BL/6J-Rag1tm1Mom/Nimr (Rag1-deficient), and C57BL/6J-Tg(TcraTcrb)
425Cbn/Nimr (OT-II) (18). All mice were bred under specific pathogen-
free conditions at the National Institute for Medical Research. Radiation
chimeras were generated as described previously (19).
Immunizations
Micewere injected i.p. with PBS containing 109 SRBC (Innovative Research),
50 mg NP (4-hydroxy-3-nitrophenylacetyl)(0.6)-LPS in PBS, 50 mg NP(40)-
AECM-Ficoll in PBS, 50 mg NP(21)-CGG (all BioSearch Technologies) in
Alum (Thermo Scientific) with PBS for primary immunizations, or 50 mg
NP(21)-CGG in PBS for rechallenge and were bled or sacrificed at various
time points for analysis or cell sorting. For cholera toxin (CTX) immu-
nization, food was withdrawn from mice 3 h before being orally gavaged
first with 1.5% NaHCO3 and then with 125 mg/kg CTX from Vibrio
cholerae Inaba 569B (List Biological Laboratories) in PBS. Blood was
withdrawn at the indicated time points. Mice were sacrificed 14 d after
immunization to obtain fecal samples from the small intestine.
Flow cytometry, cell sorting, and cell enrichment
RBC-lysed single-cell suspensions were stained in ice-cold PBS containing
LIVE/DEAD fixable near-IR dead cell stain (Life Technologies) and the
appropriate pretitered Abs. Cell numbers in the bone marrow are quoted per
leg (one femur and one tibia). B10 cells were purified using the Miltenyi
Biotec Regulatory B cell isolation kit with 24-h in vitro stimulation followed
by flow cytometric sorting for B220+CD19+IL-10+ cells. To isolate plasma
cells and plasmablasts, we enriched organ suspensions from mice immu-
nized 5 d earlier with SRBC for CD138+ cells by staining with anti–
CD138-PE and then using anti-PE beads (Miltenyi Biotec). To isolate
germinal center B cells, we depleted splenocytes from mice immunized
10 d earlier with SRBC using anti–CD43-biotin and anti–IgD-biotin fol-
lowed by streptavidin-Dynabeads (Life Technologies) and then sorted for
B220+PNA+GL7+Fas+CD38low. Data were collected on a BD FACSCanto
II or sorted on BD FACSAria II, BD Influx, or Beckman Coulter MoFlo
XDP cell sorters. Data were analyzed using FlowJo 9.6 (TreeStar).
Cell culture
B cells were purified from RBC-lysed single-cell suspensions by magnetic
negative depletion using biotinylated Abs against CD43, CD11c, CD11b,
and Ly6G and streptavidin-Dynabeads. B cells were cultured in DMEM,
100 mM nonessential amino acids, 20 mM HEPES buffer, 10% FCS, 100
U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 100 mM 2-
ME. Unless indicated otherwise, cells were stimulated with 10 mg/ml anti-
IgM F(ab)2 (Jackson Immunoresearch), 10 mg/ml LPS (Alexis), 1 mg/ml
CD40L (R&D Systems), 100 ng/ml IL-4, 100 ng/ml BAFF (both Pepro-
tech), 50 ng/ml PMA, or 500 ng/ml ionomycin (both Sigma-Aldrich).
Proliferation, survival and cytokine secretion
B cells were isolated and cultured as described above but labeled with 5 mM
CFSE in PBS for 10 min at 37˚C before culturing for 72 h. Proliferation
was assessed by CFSE dilution and number of live cells was measured by
a LIVE/DEAD fixable near-IR dead cell stain and counted using PerCP-
beads on a flow cytometer. To measure cytokine secretion, B cells were
cultured for 48 or 72 h and cytokines in the supernatants were measured
with the 16-plex Fluorokine MAP assay (R&D Systems) on a Luminex 100
machine.
Quantitative RT-PCR
Total RNA was extracted with RNEasy Mini or Micro Plus kits (Qiagen)
followed by cDNA synthesis using the Superscript III First Strand Syn-
thesis SuperMix for quantitative RT-PCR (qRT-PCR) kit (Life Technolo-
gies). Samples were analyzed on an ABI Fast 7900HT under standard
conditions using the TaqMan Gene Expression Assays (Life Technolo-
gies). Data were normalized to HRPT1 and analyzed using the comparative
threshold cycle method.
Immunoblotting
Splenic B cells were purified by depletion with biotinylated anti-CD43 Ab
and streptavidin-Dynabeads. Cell lysates were prepared using radio-
immunoprecipitation assay buffer containing protease inhibitors. Cell
debris was removed by centrifugation. Proteins were separated in 7%
SDS-PAGE gels and wet-blotted onto Immobilon-FL polyvinylidene
difluoride membrane (Millipore) by standard techniques. Membranes were
blocked in Odyssey Blocking Buffer (Li-Cor), and then probed with anti-
Themis2 exon 4 (sc-160439; Santa Cruz), anti-Themis2 exon 6 (AP9910b;
Abgent), or anti–a-tubulin mouse monoclonal (clone TAT-1), followed by
appropriate secondary Abs. Signals were detected with an Odyssey In-
frared Imager (Li-Cor) and analyzed with the manufacturer’s software.
RNA sequencing
Follicular B cells were sorted by flow cytometry. Unstimulated samples
were lysed directly, and stimulated samples were cultured as described at
33 106 cells/ml for 6 h with the indicated stimuli. RNAwas isolated using
TRIzol and cleaned up using RNeasy mini kit. Single-end, unstranded,
poly-A–enriched libraries were made using the TruSeq RNA sample
preparation kit (Illumina). Samples were analyzed with an Illumina HiSeq
2000, collecting 13.2–76.1 million reads of 75 bases per sample. Reads were
aligned to mm10 (Ensembl version 72) using Tophat (version 2.0.9). Raw
counts were determined using the union method in htseq-count (version
0.5.4p3), and mappings were filtered for a phred score .10. edgeR (version
3.2.4) was used for filtration of lowly expressed features, normalization, and
statistical analysis. Statistical significance of differences in gene expression
was determined using the exact binomial test, reporting differences with
a false discovery rate ,0.05 (20). For VDJ analysis, reads were mapped to
NCBI37/mm10 including an update containing additional VDJ annotation
derived from GenBank entries (Avadis NGS). Aligned reads were mapped to
the RefSeq transcripts database and normalized by DESeq (21). Gene ex-
pression is presented as read density defined as normalized counts per kb of
exon. All RNA sequencing (RNAseq) data are deposited in ArrayExpress
(https://www.ebi.ac.uk/arrayexpress) with accession number E-MTAB-2499.
Ag-presentation assay
Splenic B cells were isolated using magnetic negative depletion with PE-
conjugated Abs against CD43, CD11b, CD11c, and TCRb and anti-PE
beads. Splenic and lymph node CD4+ T cells from OT-II Rag1–deficient
mice were isolated using depletion with PE-conjugated Abs against CD11b,
CD11c, CD8, and B220. To activate B cells and deliver Ag to the BCR, we
stained B cells with 2.5, 0.25, 0.025, or 0 mg/ml anti–IgM F(ab)2-biotin and
then with OVA Ag delivery reagent (Miltenyi Biotec). A total of 2 3 105
B cells were cocultured with 105 OT-II CD4+ T cells in 96-well plates for
72 h. T cell activation was assessed by IL-2 production and measured in the
supernatants using the DuoSet mouse IL-2 ELISA (R&D Systems).
BCR internalization assay
Splenocytes were stained on ice with 10 mg/ml anti-IgM F(ab)2-biotin,
incubated at 37˚C for the indicated times, and BCR internalization stopped
with PBS at 0˚C. Remaining surface BCR was stained with streptavidin-PE
and analyzed by flow cytometry.
Influenza infection
Mice were infected intranasally with 30 ml PBS containing X31 influenza
50% tissue culture infective dose = 8 3 103 or 8 3 104 and monitored
daily for weight loss and clinical symptoms for 15 d and bled at day 10.
Mice that reached 75% of their starting weight were euthanized.
Ig ELISAs
Total serum Ig levels were quantified by ELISAwith the SBA Clonotyping
System-B6/C57J-HRP (Southern Biotech) according to the manufacturer’s
instructions and were revealed with 3,39,5,59-tetramethylbenzidine. Signals
were quantified using OD at 450 nm of serial dilutions, taking values in the
linear portion of the response curve to calculate Ab levels. NP-specific and
CTX-specific ELISAs were performed analogously, but plates were coated
with 5 mg/ml NP18-BSA (BioSearch Technologies) or 1 mg/ml CTX, re-
spectively. For determination of anti-X31 HA-IgG, plates were coated with
2.5 mg/ml of purified X31 HA (John Skehel, National Institute for Medical
Research). Serial dilutions of heat-inactivated sera samples were detected
with HRP-conjugated goat anti-mouse IgG (Bio-Rad) and 3,39,5,59-tetra-
methylbenzidine.
Statistical analysis
Statistical analysis was carried out using a Mann–Whitney U test.
Results
Themis2 is the only Themis-family member expressed in the
B cell lineage
We first measured expression of Themis-family genes in the B cell
lineage. RNAseq analysis of mRNA isolated from mouse splenic
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follicular B cells showed expression of Themis2, but no detectable
expression of either of the closely related Themis1 or Themis3
genes, or of Garem and Gareml (Fig. 1A). To extend this analysis,
we examined expression of the Themis-family genes in develop-
ing subsets of B lineage cells in the bone marrow (pro-B, pre-B,
immature B, and mature recirculating B cells) and the spleen
(transitional type 1 [T1], T2, and T3 B cells), and in mature B cell
subsets in the spleen (follicular and marginal zone B cells), lymph
nodes (follicular B cells), and peritoneal cavity (B1 and B2 cells).
As a positive control for expression of Themis1, we used mRNA
isolated from the thymus and from splenic and lymph node
T cells, and for Themis3 we used mRNA from the small intestine.
We found that Themis2 is expressed in all B cell subsets, both
developing and mature, with very little or no detectable expression
of either Themis1 or Themis3 (Fig. 1B). In contrast, thymocytes
and T cells express Themis1, but not Themis2 or Themis3, and the
small intestine expresses exclusively Themis3. Finally, we exam-
ined expression of Themis-family genes in Ag-activated B cells.
Once again we found expression of Themis2, but not Themis1 or
Themis3, in germinal center B cells, IL-10–secreting B cells (B10
cells), plasmablasts, and plasma cells in the spleen and in plasma
cells in the bone marrow (Fig. 1C). However, we noted that ex-
pression of Themis2 was significantly lower in germinal center
B cells and B10 cells compared with follicular B cells (p = 0.017
and 0.006, respectively). Thus, of the Themis-family, only The-
mis2 is expressed in the B cell lineage, with expression detectable
in all B cell subsets, although the levels are reduced in Ag-
activated B cells.
Themis2-deficient mice
To study the function of Themis2 in B cells, we generated
Themis2-deficient mice on a C57BL/6 background carrying the
Themis2tm1d(KOMP)Wtsi (Themis2KO) allele in which exon 4 is de-
leted. Themis2KO/KO mice were viable and produced at expected
ratios from heterozygous parents. Exon 4 is the largest exon in the
Themis2 gene and encodes the C terminus of the first CABIT
domain, the whole second CABIT domain, NLS, and PRR. De-
letion of exon 4 leads to a frameshift between exons 3 and 5, and
is thus predicted to eliminate expression of the C terminus of the
protein, including Y660, the proposed SH2 domain-binding site.
Analysis of Themis2 mRNA in splenic B cells from Themis2KO/KO
mice showed, as expected, no detectable mRNA spanning exons
3–4 and exons 4–5 (Fig. 2A). In contrast, mutant B cells contained
normal levels of mRNA spanning exons 2–3 and exons 5–6, and
showed splicing from exons 3–5, which was not detectable in
wild-type (WT) B cells (Fig. 2A, Supplemental Fig. 2A). We
conclude that the effect of the Themis2KO mutation is to generate
FIGURE 1. Themis2 is the only Themis-family gene
expressed in the B cell lineage. (A) Mean (6 SEM)
mRNA levels of CABIT domain–containing proteins in
follicular B cells, measured by RNAseq, displayed as
read density. (B and C) Mean (6 SEM) mRNA levels of
Themis-family genes in the indicated organs or cell
types, measured by qRT-PCR. All cell types were pu-
rified by flow cytometric sorting using gating strategies
shown in Supplemental Fig. 1. Data are from $3 bio-
logical replicates per population. GC, germinal center
B cell; LN, lymph node; MZ, marginal zone B cell; n.d.,
not detected; PB, plasmablast; PC, plasma cell; PEC,
peritoneal exudate cell.
FIGURE 2. Themis2KO/KO mice express a truncated and frame-shifted
Themis2 transcript. (A) Mean (6 SEM) mRNA expression of Themis2
mRNA across the indicated exon junctions determined by qRT-PCR in
splenic B cells from WT or Themis2KO/KO (KO) mice, normalized to ex-
pression in WT cells, which was set to 1. Data are from $2 biological
replicates. (B) Immunoblots of total cell lysates from splenic B cells from
WT or KO mice probed with Abs to epitopes of Themis2 encoded in exons
4 or 6, and to a-tubulin. (C) Quantification of Themis2 relative to a-tubulin
from blots in (B), normalized to expression in WT cells, which was set to
100. Immunoblots are representative of two biological replicates. n.d., not
detected.
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a truncated transcript in which exon 3 is spliced to exon 5. Im-
munoblot analysis of Themis2KO/KO splenic B cell extracts probed
with Abs to epitopes in exons 4 and 6 showed no detectable full-
length or truncated Themis2 protein (Fig. 2B, 2C). Thus, the mutant
allele has eliminated expression of full-length Themis2. However,
in the absence of Abs to epitopes in exons 1–3, we cannot exclude
that a short N-terminal fragment of Themis2 is still generated, al-
though we note that such a hypothetical protein would contain only
part of the first CABIT domain, and no other domain of Themis2.
Normal B cell development in the absence of Themis2
To investigate whether Themis2 is required for B cell development,
we used flow cytometric analysis to quantitate the numbers of
developing and mature B cells in lymphoid tissues of Themis2KO/KO
mice. We found that the numbers of pro-B, pre-B, immature B, and
mature B cells in the bone marrow, and T1, T2, and T3 cells in the
spleen were unaltered in the mutant mice (Fig. 3A, Supplemental
Fig. 1). Furthermore, there were also no changes in the numbers of
mature follicular and marginal zone B cells in the spleen, B1a, B1b,
and B2 cells in the peritoneal cavity, and B cells in blood, Peyer’s
patches, and peripheral and mesenteric lymph nodes. Finally, we
examined Ag-experienced B cells and found that loss of Themis2
did not change the number of plasma cells in the bone marrow, and
numbers of germinal center B cells, B10 cells, plasmablasts, and
plasma cells in the spleen. We also saw no effect on cell-surface
levels of marker proteins on any of these cell types (Supplemental
Fig. 1). To extend this analysis, we generated radiation chimeras
reconstituted with mixtures of Themis2-deficient and WT bone
marrow. Such mixed chimeras provide a competitive environment
in which small defects in B cell development are more likely to be
apparent. However, these studies once again showed no defect in the
ability of Themis2-deficient progenitors to contribute to developing
or mature B cell subsets, irrespective of whether the mutant cells
made up 50 or 20% of the hematopoietic system (Supplemental
Fig. 2B).
To analyze the development of Themis2-deficient B cells further,
we used RNAseq to compare genome-wide gene expression be-
tween WTand mutant follicular B cells. This analysis showed only
three genes that were differentially regulated .2-fold between the
two genotypes (Fig. 3B, Supplemental Table 1A). We used these
data to also examine usage of variable (V), diversity (D), joining
(J), and constant (C) region genes for both heavy (H) and light
(k and l) Ig chains. Alterations in usage of the V, D, or J region
genes could indicate changes in positive or negative selection
processes during B cell development. However, we found that
usage of VH, DH, JH, Vk, Jk, Vl, and Jl genes was largely identical
between WT and Themis2-deficient B cells, as was usage of CH,
Ck, and Cl genes (Fig. 3C, Supplemental Fig. 3). Taken together,
these results indicate that B cell development proceeds normally
in Themis2KO/KO mice.
FIGURE 3. Normal B cell development in Themis2KO/KO
mice. (A) Numbers of B and T cell populations in the
indicated organs of Themis2KO/KO and WT mice. Cell
populations were analyzed using the gating strategy
shown in Supplemental Fig. 1. Bars represent mean 6
SEM of eight biological replicates. (B) Scatterplot
showing comparison of gene expression in splenic
follicular B cells from Themis2KO/KO and WT mice
measured by RNAseq and displayed as read density.
Each dot is a different gene, dotted lines indicate read
density = 1, and dashed lines indicate 2-fold deregu-
lation thresholds. A value of 1024 was added to the read
density values so that genes with read density = 0 could
be displayed on a logarithmic plot. Data are mean of
three biological replicates per genotype. (C) Expression
of VH genes in splenic follicular B cells from mice of
the indicated genotypes as determined by RNAseq. VH
genes are ordered by level expression in WT mice. Data
are mean (6 SEM) of three biological replicates. mLN,
mesenteric lymph node; pLN, peripheral lymph node.
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Themis2-deficient B cells are activated normally in response to
in vitro stimulation
To evaluate a potential role for Themis2 during B cell activation, we
first analyzed expression of Themis-family genes in B cells after
stimulation in vitro with anti-IgM, LPS, or CD40L and IL-4. We
found that the expression of Themis2 decreased rapidly in response
to all three stimuli, reaching a low point after around 6 h, after
which the expression increased again (Fig. 4A, 4B). The levels of
all other Themis-family genes (Themis1, Themis3, Garem, and
Gareml) remained very low or undetectable. Furthermore, RNA-
seq analysis of Themis2KO/KO B cells activated by anti-IgM, LPS,
or with CD40L and IL-4, showed that no other Themis-family
gene was upregulated to compensate for loss of Themis2 (Fig.
4B). Thus, in activated B cells, Themis2 is the only Themis-family
gene expressed, and even in the absence of Themis2, no other
family member is expressed.
Next, we examined the upregulation of cell-surface markers on
WT and Themis2KO/KO B cells after activation by anti-IgM, LPS,
or with CD40L and IL-4. We found that in response to a range of
different doses of these stimuli, the upregulation of CD69, CD23,
CD86, and MHC class II was no different in Themis2-deficient
B cells compared with WT B cells (Fig. 4C). Furthermore, lack of
Themis2 also did not affect either the proliferation or survival of
B cells in response to these stimuli (Fig. 4D). BAFFR, a receptor
for the cytokine BAFF, transduces signals critical for B cell sur-
vival in part via the BCR (19, 22), and thus if Themis2 is involved
in BCR signaling, it may also be required for BAFFR signaling.
We investigated this possibility by treating WT or Themis2-
deficient B cells with BAFF, but found that loss of Themis2 did
not affect upregulation of CD86 or MHC class II, or BAFF-
induced cell survival (Fig. 4C, 4D).
To extend this analysis, we measured secretion of 16 different
cytokines (CCL2, CXCL1, CXCL2, GM-CSF, IFN-g, IL-1b, IL-2,
IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, IL-17, TNF-a, and VEGF)
after in vitro stimulation of B cells with anti-IgM, LPS, or with
CD40L and IL-4. Depending on the stimulus, we were able to
detect substantial secretion of only four of these cytokines (IL-6,
IL-10, TNF-a, and VEGF), but in all cases, loss of Themis2 did
not affect the secretion of these proteins (Fig. 5A). RNAseq
studies to measure gene expression in mutant or WT B cells
stimulated with anti-IgM, LPS, or CD40L and IL-4 showed that
in these 3 conditions, only 3, 8, and 17 genes, respectively,
were differentially expressed .2-fold between Themis2-deficient
and control B cells (Fig. 5B, Supplemental Table 1B–D). In
FIGURE 4. Themis2 is not required
for B cell activation, survival, or prolif-
eration. (A) Relative mRNA expression
data of CABIT domain–containing pro-
teins after in vitro activation of splenic B
cells with various stimuli for the indi-
cated time, determined by qRT-PCR.
Where data points for Themis1, Garem,
or Gareml are missing the transcript could
not be detected; Themis3 could not be
detected at any time point. Graphs indi-
cate mean 6 SEM of three biological
replicates and are representative of two
independent experiments. (B) Expression
of mRNA for Themis-family proteins in
splenic follicular B cells from WT or
Themis2KO/KO mice either unstimulated
or activated by the indicated stimuli
for 6 h. Expression was determined by
RNAseq and is shown as mean 6 SEM
RPKM (reads per kb per million reads)
of one to three biological replicates. Ex-
pression of Themis1, Themis3, Garem,
and Gareml was not detectable. Unsti-
mulated WT data are from the same ex-
periment as in Fig 1A. (C) Geometric
mean fluorescence intensity (gMFI, ar-
bitrary units) measured by flow cytom-
etry of CD69, CD23, CD86, and MHC
class II on splenic B cells in response to
various stimuli after in vitro culture for
24 h. Concentrations of stimuli are indi-
cated. Bars indicate mean6 SEM of three
biological replicates and are representative
of five similar experiments. (D) Splenic B
cells from WT or Themis2KO/KO mice
were cultured for 72 h with the indicated
stimuli. Graphs indicate mean 6 SEM
percentage of cells that had divided and
numbers of live B cells. Data shown are
from three biological replicates and are
representative of three similar experiments.
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conclusion, Themis2KO/KO follicular B cells are transcriptionally
very similar to WT B cells, both before and after activation.
Finally, we examined the ability of Themis2-deficient B cells to
internalize and present Ag. Stimulation of splenic B cells with anti-
IgM to cross-link the BCR led to internalization of the receptor at
the same rate in both WTand Themis2-deficient cells (Fig. 5C). To
measure the ability of Themis2KO/KO B cells to present Ag to
FIGURE 5. Normal cytokine secretion, gene expression, and Ag pre-
sentation by Themis2-deficient B cells. (A) Cytokines in the supernatant of B
cells cultured for 72 h in the presence of the indicated stimuli. Graphs show
mean 6 SEM of three biological replicates and are representative of three
independent experiments. (B) Scatterplots formatted as in Fig. 3B showing
comparison of gene expression in splenic B cells from Themis2KO/KO and
WT mice cultured in the presence of the indicated stimuli for 6 h, measured
by RNAseq. (C) Surface levels of BCR as a function of time on WT or
Themis2KO/KO splenic B cells stimulated with anti-IgM F(ab)2. Graph shows
mean 6 SEM of three biological replicates and is representative of three
independent experiments. (D) IL-2 secretion by OT-II T cells cocultured for
72 h with WT or Themis2KO/KO splenic B cells that had been preloaded with
low, medium, or high doses of OVA Ag, or with no Ag. As a control, OT-II
T cells were also either cocultured alone or with B cells that had been given
a high dose of OVA Ag and then fixed. Neither of the latter conditions
resulted in any detectable IL-2 secretion, confirming that cytokine secretion
by the T cells was dependent on Ag internalization and presentation by B
cells. No IL-2 was detected in the absence of T cells (data not shown). Graph
shows mean 6 SEM of two to three biological replicates and is represen-
tative of two independent experiments.
FIGURE 6. Normal Ab responses in Themis2-deficient mice. (A) Serum
levels of Ig isotypes in WT and Themis2KO/KO mice. Graph shows mean 6
SEM of six biological replicates. (B–D) NP-specific serum Ig levels in WT
and Themis2KO/KO mice as a function of time after immunization with NP-
LPS (B), NP-Ficoll (C), or NP-CGG in alum (D) on day 0. Mice immu-
nized with NP-CGG were rechallenged with NP-CGG in PBS on day 63.
Graphs show mean 6 SEM of six biological replicates per group. (E)
CTX-specific serum Ig levels as a function of time or (F) fecal Ig levels on
day 14 in WT and Themis2KO/KO mice after oral CTX immunization. a.u.
arbitrary unit; n.s. not significant.
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T cells, we treated B cells with an anti–IgM-OVA conjugate and
then incubated them with OT-II CD4+ T cells bearing a mono-
clonal TCR specific for an OVA peptide (18) and assayed IL-2
secretion from the T cells as a readout of T cell activation. We
found that at three different OVA doses, Themis2-deficient B cells
were able to present Ag just as efficiently as WT B cells (Fig. 5D).
Taken together, these results show that loss of Themis2 does not
perturb B cell activation in vitro or their ability to present Ag to
T cells.
Normal Ab responses in Themis2-deficient mice
Next, we investigated whether Themis2 was required for in vivo Ab
responses. Themis2-deficient mice had normal levels of serum Ig
isotypes (Fig. 6A). Immunization of mice with the T-independent
type I Ag NP-LPS showed that WT and Themis2-deficient mice
induce very similar levels of NP-specific IgM, IgG1, and IgG3
(Fig. 6B). Similarly, the Ab response of Themis2-deficient mice to
the T-independent type II Ag NP-Ficoll was also normal (Fig. 6C).
Analysis of mice immunized with NP-CGG (chicken g-globulin)
in alum, a T-dependent Ag, showed that Themis2KO/KO mice
mount a normal anti-NP IgM and IgG1 response (Fig. 6D). The
same mice were rechallenged on day 63 with NP-CGG in PBS,
and both mutant and control mice showed robust Ag-specific sec-
ondary responses (Fig. 6D). Finally, we evaluated the ability of
Themis2-deficient mice to mount a mucosal Ab response to orally
delivered CTX. Once again, Themis2KO/KO mice showed a normal
CTX-specific Ab response both in the serum and in feces (Fig. 6E,
6F). Taken together, these data clearly demonstrate that Themis2 is
dispensable for Ab responses, at least to model Ags.
Resistance to influenza infection is unchanged in
Themis2-deficient mice
Finally, we assessed the ability of Themis2-deficient mice to mount
an immune response to a pathogen. Control and Themis2KO/KO
mice were challenged intranasally with influenza virus, using ei-
ther a low dose of virus from which most C57BL/6 mice survive,
or a high dose, which is usually lethal. With both doses, Themis2-
deficient mice showed weight loss and mortality rates that were
similar to WT mice, and both genotypes of mice generated similar
levels of serum IgG specific to influenza HA protein (Fig. 7A–C).
Thus, Themis2 does not appear to play an important role in the
immune response to infection by influenza virus. Because Themis2
is expressed in myeloid cells such as macrophages and dendritic
cells, in addition to B cells, and these cell types play important roles
in an antiviral immune response (23), we conclude that Themis2
plays no critical role in the antiviral immune response, both in
B cells and in myeloid cells.
Discussion
Previous studies demonstrating a critical role for Themis1 in T cell
development and activation, and the reported reciprocal mutually
exclusive expression of Themis1 in T cells and Themis2 in B cells,
led us to hypothesize that Themis2 may play an analogous im-
portant role in B cell development, activation, or function. Such
a possible related function was further supported by the report that
ectopic expression of Themis2 in the T cell lineage rescues thy-
mocyte development in Themis1-deficient mice (7). We show in
this article that the only Themis-family member expressed in B
lineage cells is Themis2, with no expression of either Themis1 or
Themis3, or of the single CABIT domain proteins Garem and
Gareml. Furthermore, we show that this exclusive expression is
seen in all subsets of B cells examined, including developing B cells
in the marrow, mature B cells in the spleen and lymph nodes, B1
cells in the peritoneal cavity, and in activated B cell subsets.
Comparison of Themis2 expression showed that germinal center
B cells and B10 cells have the lowest level of expression, suggesting
that activation of B cells results in a decrease in Themis2 expres-
sion. In agreement with this, we found that activation of B cells
in vitro with anti-IgM, LPS, and CD40L+IL-4 results in a rapid
decline of Themis2 expression, with no compensating upregulation
of expression of any other Themis-family gene. Similarly, previous
studies had shown that expression of Themis2 in macrophages is
reduced in mice undergoing infection or inflammation (6).
To investigate the function of Themis2, we generated a mouse
strain deficient in Themis2 by deleting exon 4 of Themis2. The
resulting Themis2 allele is still transcribed, resulting in an mRNA
with exon 3 spliced to exon 5, which is predicted to result in
a frameshift and subsequent termination of translation in exon 6.
As expected, immunoblot analysis of B cell extracts from these
mutant mice showed that no full-length or truncated Themis2
protein was detectable using Abs recognizing epitopes in exons 4
and 6. It remains possible that an N-terminal fragment of Themis2
is still made in this strain, although we were unable to test for this
in the absence of Abs to epitopes encoded by exons 1, 2, or 3 of
FIGURE 7. Themis2KO/KO mice respond normally to
influenza infection. (A) Weight of WT or Themis2KO/KO
mice as a function of time after intranasal infection with
X31 influenza 50% tissue culture infective dose = 8 3 103
(low dose) or 8 3 104 (high dose). Data beyond day 7 for
the high-dose group is not shown because of high mortality.
Graphs show mean 6 SEM of six mice per group. (B)
Kaplan–Meier survival curve of WT or Themis2KO/KO mice
from the experiment shown in (A). (C) Titer of anti-HA IgG
in serum from mice 10 d after X31 influenza infection. Bars
indicate mean 6 SEM of four to six mice per group. a.u.,
arbitrary unit.
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Themis2. However, such a hypothetical truncated Themis2 protein
would include only the N-terminal part of the first CABIT domain
of Themis2. It would not contain the rest of this domain, the
second CABIT domain, NLS, PRR, or Y660.
It is unlikely that such a truncated protein would be functional for
several reasons. First, the PRR and Y660 of Themis2 are required in
macrophages for binding of Themis2 to Grb2 and Lyn, respectively
(6). Second, mutation of either the PRR or Y660 impairs the
ability of Themis2 to promote LPS-induced release of TNF-a.
Third, the PRR of Themis1 is required for binding to Grb2 in
T cells and for the recruitment of Themis1 to the LAT adapter
protein, and hence the immunological synapse (12). Fourth, the
CABIT domains, NLS and PRR of Themis1, are required for
normal T cell development (11). Finally, a point mutation in the
C-terminal end of the second CABIT domain of Themis1 leading
to a premature stop codon also abrogates thymocyte development,
demonstrating that a Themis1 protein containing only the first
CABIT domain is not sufficient to maintain normal function (1).
Taken together, these results suggest that if a truncated Themis2
protein is generated from the Themis2KO allele, it is unlikely to be
functional.
Analysis of Themis2KO/KO mice showed that, surprisingly,
Themis2 is not required for normal B cell development. No de-
velopmental defect was seen even under competitive conditions,
where small deficits are more likely to be visible. Analysis of V,
D, and J gene usage for both H and L chain Ig genes showed no
significant changes in Themis2-deficient mice, indicating that loss
of Themis2 did not measurably affect B cell selection. Similarly,
loss of Themis2 did not affect in vitro activation of B cells in
response to stimulation through the BCR, TLR4, CD40, or IL4R,
and did not perturb BCR internalization or Ag presentation to
T cells. Finally, Themis2 was not required for Ab responses either
to T-independent or T-dependent model Ags, or to influenza virus
during the immune response to infection.
This lack of phenotype could potentially be because of func-
tional redundancy between Themis2 and other related proteins.
However, RNAseq analysis showed that Themis2-deficient B cells
did not upregulate expression of other Themis-family genes. Thus,
B lineage cells in Themis2KO/KO mice do not express any Themis-
family member, making it unlikely that the lack of phenotype in
Themis2KO/KO mice is due to redundancy with Themis-family
proteins. Another possibility for the lack of phenotype is that
the Themis2 gene is nonfunctional. This is unlikely for two rea-
sons. First, the Themis2 gene is found in all vertebrates, indicating
that Themis2 is likely to have an important function (1). Second, it
is possible that the Themis2 gene in laboratory mice has become
nonfunctional. However, this is also unlikely because ectopic
expression of mouse Themis2 in the T cell lineage can rescue
T cell development in Themis1-deficient mice (7). Taken together,
these observations suggest that Themis2 has an important physi-
ological role, but not in the processes examined in this study. We
note that Themis2 is expressed in myeloid cells, and it may be that
Themis2 is more important in these cells.
In summary, we have shown that Themis2 is expressed in all
subsets of developing, mature and activated B cells. Surprisingly,
however, loss of Themis2 does not perturb B cell development,
activation, or Ab responses. Further studies are needed to identify
the physiological function of this conserved protein.
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